secwatch.observer — SEC 8-K summary
======================================

Issuer:     ZyVersa Therapeutics, Inc. (ZVSA)
CIK:        0001859007
Form:       8-K
Filed at:   2023-11-17T23:59:59+00:00
Accession:  0001493152-23-041884
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

ZyVersa receives Nasdaq delisting determination over low bid price; hearing requested
--------------------------------------------------------------------------------

- Nasdaq determined to delist on Nov 16, but company requested hearing, staying delisting pending panel decision.
- Stock closed at $0.10 or less for 10 consecutive days, triggering Low Priced Stocks Rule.
- Company had until Dec 6, 2023 to regain $1.00 bid compliance; low price accelerated delisting.
- Stockholders approved reverse stock split (1:10-1:50) at Oct 31 meeting; may be used to regain compliance.
- No assurance of favorable hearing outcome or extension; stock continues trading under ZVSA.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1859007/000149315223041884/0001493152-23-041884-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1859007/000149315223041884/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-041884

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer